These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38137445)

  • 21. Oncostatin M pathway plays a major role in the renal acute phase response.
    Luyckx VA; Cairo LV; Compston CA; Phan WL; Mueller TF
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F875-83. PubMed ID: 19158344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
    Repovic P; Mi K; Benveniste EN
    Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor.
    Chollangi S; Mather T; Rodgers KK; Ash JD
    J Biol Chem; 2012 Sep; 287(39):32848-59. PubMed ID: 22829597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncostatin-M Does Not Predict Treatment Response in Inflammatory Bowel Disease in a Pediatric Cohort.
    Ezirike Ladipo J; He Z; Chikwava K; Robbins K; Beri J; Molle-Rios Z
    J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):352-357. PubMed ID: 34117193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.
    Jakob L; Müller TA; Rassner M; Kleinfelder H; Veratti P; Mitschke J; Miething C; Oostendorp RAJ; Pfeifer D; Waterhouse M; Duyster J
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
    J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure.
    Kubin T; Gajawada P; Bramlage P; Hein S; Berge B; Cetinkaya A; Burger H; Schönburg M; Schaper W; Choi YH; Richter M
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling.
    Feng Y; Yuan Y; Xia H; Wang Z; Che Y; Hu Z; Deng J; Li F; Wu Q; Bian Z; Zhou H; Shen D; Tang Q
    J Transl Med; 2023 Apr; 21(1):290. PubMed ID: 37120549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
    Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Paolini JF; Romanelli P; Yosipovitch G
    Exp Dermatol; 2021 Jun; 30(6):804-810. PubMed ID: 33428793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncostatin M and its receptors mRNA regulation in bovine granulosa and luteal cells.
    Martins KR; Haas CS; Ferst JG; Rovani MT; Goetten ALF; Duggavathi R; Bordignon V; Portela VVM; Ferreira R; Gonçalves PBD; Gasperin BG; Lucia T
    Theriogenology; 2019 Feb; 125():324-330. PubMed ID: 30504073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta.
    Faffe DS; Flynt L; Mellema M; Whitehead TR; Bourgeois K; Panettieri RA; Silverman ES; Shore SA
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1040-8. PubMed ID: 15665043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
    Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
    J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncostatin M receptor-beta signaling limits monocytic cell recruitment in acute inflammation.
    Hams E; Colmont CS; Dioszeghy V; Hammond VJ; Fielding CA; Williams AS; Tanaka M; Miyajima A; Taylor PR; Topley N; Jones SA
    J Immunol; 2008 Aug; 181(3):2174-80. PubMed ID: 18641356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members.
    Beigel F; Friedrich M; Probst C; Sotlar K; Göke B; Diegelmann J; Brand S
    PLoS One; 2014; 9(4):e93498. PubMed ID: 24710357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions.
    Ruprecht K; Kuhlmann T; Seif F; Hummel V; Kruse N; Brück W; Rieckmann P
    J Neuropathol Exp Neurol; 2001 Nov; 60(11):1087-98. PubMed ID: 11706938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncostatin M synergistically induces CXCL10 and ICAM-1 expression in IL-1beta-stimulated-human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    J Cell Biochem; 2010 Sep; 111(1):40-8. PubMed ID: 20680966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted disruption of oncostatin M receptor results in altered hematopoiesis.
    Tanaka M; Hirabayashi Y; Sekiguchi T; Inoue T; Katsuki M; Miyajima A
    Blood; 2003 Nov; 102(9):3154-62. PubMed ID: 12855584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Diffuse Type 2 Dominant or Eosinophilic Chronic Rhinosinusitis With Corticosteroid Irrigation After Surgical Neosinus Cavity Formation.
    Li W; Ho J; Grayson JW; Alvarado R; Rimmer J; Sewell WA; Campbell R; Kalish L; Sacks R; Harvey RJ
    JAMA Otolaryngol Head Neck Surg; 2021 Apr; 147(4):360-367. PubMed ID: 33538760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
    Van Wagoner NJ; Choi C; Repovic P; Benveniste EN
    J Neurochem; 2000 Aug; 75(2):563-75. PubMed ID: 10899931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity.
    Moidunny S; Matos M; Wesseling E; Banerjee S; Volsky DJ; Cunha RA; Agostinho P; Boddeke HW; Roy S
    J Neuroinflammation; 2016 Jun; 13(1):144. PubMed ID: 27287400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.